It is the intent of the general assembly to encourage Tennessee-based research institutions to participate in federally authorized ibogaine clinical trials and multistate research collaborations addressing opioid use disorder, post-traumatic stress disorder, traumatic brain injury, and other serious conditions.
Legislative purpose
Tenn. Code Ann. § 53-16-102, under HOPE Treatment Act.
Tenn. Code Ann. § 53-16-102